Search

everythinglearnresearchcommunity

for

Search:↓

Adding cetirizine to minoxidil improves hair growth and thickness in women with androgenetic alopecia.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Botulinum toxin was found to be a safe and effective treatment for male pattern baldness in a small test, but more research is needed.

Biotin deficiency is not a major cause of Telogen Effluvium hair loss.

About a quarter of the participants experienced hair loss after COVID-19 vaccination.

The hair lotion reduced hair loss and sped up recovery in women with acute telogen effluvium.

Treating hair loss effectively may require a multi-sided approach, using different treatments together, and topical treatments could be more effective and safer than oral ones.

The supplement significantly improves hair density and appearance in people with hair loss.

Nanocarriers with plant extracts show promise for safe and effective hair growth treatment.

About 61% of women who had COVID-19 experienced hair loss afterward.

Trichoscopy is useful for quickly diagnosing different types of hair loss without needing biopsies.

Oral minoxidil helps with hair growth but needs more research to fully understand its effectiveness and safety.

Trichoscopy is a reliable method for diagnosing hair and scalp disorders quickly and non-invasively.

Stem cell treatments show promise for hair loss but need more research.

Topical procyanidin B2 significantly increases hair count and is a safe treatment for male pattern baldness.

TRPS1 loss in balding scalp areas contributes to hair loss in androgenic alopecia.

A patient with hair loss condition grew excessive hair in areas covered by a cast.

Sunscreen particles were not found in inflamed or fibrotic areas of skin in FFA patients, suggesting no direct link to the disease.

New criteria for diagnosing frontal fibrosing alopecia include specific scalp and eyebrow hair loss as major factors and other hair loss areas and hair analysis as minor factors.

Trichoscopy effectively diagnoses eyebrow loss, distinguishing between alopecia areata and frontal fibrosing alopecia.

Frontal Fibrosing Alopecia may be linked to autoimmune diseases like Sjögren's syndrome.

The conclusion is that having both Frontal Fibrosing Alopecia and Discoid Lupus Erythematosus may suggest a shared immune response in certain people, and a mix of antimalarial drugs and 5-alfa-reductase inhibitors is recommended for treatment.

Trichoscopy of the beard is useful for diagnosing frontal fibrosing alopecia in men.

Dutasteride can stabilize hair loss in patients with frontal fibrosing alopecia, but its safety in women is unclear, so use it with caution.

D-OCT shows increased blood vessel growth in response to tissue damage in Frontal Fibrosing Alopecia and is useful for diagnosis and monitoring.

Snail1 may contribute to fibrosis in frontal fibrosing alopecia in postmenopausal women.

Some women with Frontal Fibrosing Alopecia also have Lichen Planopilaris, which can lead to more symptoms and affect hair outside the scalp.

A male patient developed frontal fibrosing alopecia after antiandrogen therapy for prostate cancer.

Frontal Fibrosing Alopecia is a type of hair loss that mainly affects postmenopausal women, has unclear causes, and lacks evidence-based treatments.

The letter discusses a disagreement about the definition of the "frontal area" in hair restoration surgery and questions the effectiveness of treatments like finasteride and minoxidil on this area.